René St-Arnaud¹, G. Antonio Candeliere¹, and Shoukat Dedhar²

¹Genetics Unit, Shriners Hospital, and Departments of Surgery and Human Genetics, McGill University, Montréal (Québec) Canada H3G1A6

²Division of Cancer Research and Department of Medical Biophysics, University of Toronto, Reichmann Research Building, Sunnybrook Health Science Centre, Toronto (Ontario) Canada M4N 3M5

Received 07/05/96; Accepted 07/12/96; On-line 08/01/96

1. B.E. Kream, D.W. Rowe, G. Gworek & L.G. Raisz: Parathyroid hormone alters collagen synthesis and procollagen mRNA levels in fetal rat calvaria. Proc Natl Acad Sci USA 77,5654-8 (1980)

2. F.R. Bringhurst & J.T. Potts Jr:: Bone collagen synthesis in vitro: Structure/activity relations among parathyroid hormone fragments and analogs. Endocrinology 108,103-8 (1981)

3. D.W. Row & B.E. Kream: Regulation of collagen synthesis in fetal rat calvaria by 1,25-dihydroxyvitamin D3. J Biol Chem 257,8009-15 (1982)

4. D.M. Rosen & R.A. Luben: Multiple hormonal mechanisms for the control of collagen synthesis in an osteoblast-like cell line, MMB-1. Endocrinology 112,992-9 (1983)

5. B.E. Kream, D.W. Rowe, M.D. Smith, V. Maher & R Majeska: Hormonal regulation of collagen production in a clonal rat osteosarcoma cell line. Endocrinology 119,1922-8 (1986)

6. S.C. Manolagas, D.W. Burton & L.J. Deftos: 1,25-dihydroxyvitamin D₃ stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256,7115-7 (1981)

7. R.J. Majeska & G.A. Rodan: The effects of 1,25 (OH)₂D₃ on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257,13362-5 (1982)

8. N. Kurihata, K. Ikeda, Y. Hakeda, M. Tsunoi, N. Maeda & M. Kumegawa : Effect of 1,25-dihydroxyvitamin D₃ on alkaline phosphatase activity and collagen synthesis in osteoblastic cells, clone MC3T3-E1. Biochem Biophys Res Comm 119,767-71 (1984)

9. N. Kurihara, S. Ishizuka, M. Kiyoki, Y. Haketa, K. Ikeda& M. Kumegawa: Effects of 1,25-dihydroxyvitamin D₃ on osteoblastic MC3T3-E1 cells. Endocrinology 118,940-7 (1986)

10. C.W. Prince & W.T. Butler: 1,25-dihydroxyvitamin D₃ regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Collagen Rel Res 7,305-15 (1987)

11. A. Oldberg, B. Jinskod-Hed, S. Axelsson & D. Heinegard: Regulation of bone sialoprotein mRNA by steroid hormones. J Cell Biol 109,3183-6 (1989)

12. J. Lian, C. Stewart, E. Puchacz, S. Mackowiak, V.Shalhoub, D. Collart, G. Zambeti & G. Stein : Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 84,1143-7 (1989)

13. M.B. Demay, J.M. Gerardi, H.F. DeLuca & H.M. Kronenberg: DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D₃ receptor and confer responsiveness to 1,25-dihydroxyvitamin D₃. Proc Natl Acad Sci USA 87,369-73 (1990)

14. J.D. Fraser, Y. Otawara & P.A. Price: 1,25-dihydroxyvitamin D₃ stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. J Biol Chem 263,911-6 (1988)

15. Y.H. Spiess, P.A. Price, J.L. Deftos & S.C. Manolagas: Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D₃ on alkaline phosphatase and bone Gla-protein of rat osteoblastic cells. Endocrinology 118,1340-6 (1986)

16. J.D. Fraser & P.A. Price: Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D₃ treatment of osteosarcoma cells. Calcif Tissue Int 46,270-9 (1990)

17. T. Matsumoto, C. Igarashi, Y. Takeuchi, S. Harada, T.Kikuchi, Y. Yamato & E.Ogata : Stimulation by 1,25-dihydroxyvitamin D₃ of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 12,27-32 (1991)

18. P.J. Fuller: The steroid receptor superfamily: mechanisms of diversity. FASEB J 5, 3092-9 (1991)

19. K. Ozono, T. Sone & J.W. Pike: The genomic mechanism of action of 1,25-dihydroxyvitamin D₃. J Bone Miner Res 6, 1021-7 (1991)

20. J.I. Nishikawa, M. Matsumoto, K. Sakoda, M. Kitaura, M. Imagawa & T. Nishihara: Vitamin D receptor zinc finger region binds to a direct repeat as a dimer and discriminates the spacing number between each half site. J Biol Chem 268,19739-43 (1993)

21. M. Noda, R.L. Vogel, A.M. Craig, J. Prahl, H.F. DeLuca & D.T. Denhardt: Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D₃ receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87,9995-9 (1990)

22. M.B. Demay, J.M. Gerardi, H.F. DeLuca & H.M. Kronenberg: DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D₃ receptor and confer responsiveness to 1,25-dihydroxyvitamin D₃. Proc Natl Acad Sci USA 87,369-73 (1990)

23. H.M. Darwish & H.F. DeLuca: Identification of 1,25-dihydroxyvitamin D₃-response element in the 5'-flanking region of the rat calbindin D-9k gene. Proc Natl Acad Sci USA 89,603-7 (1992)

24. X. Cao, F.P. Ross, L. Zhang, P.N. MacDonald, J. Chappel & S.L. Teitelbaum: Cloning of the promoter for the avian integrin ß₃ subunit gene and its regulation by 1,25-dihydroxyvitamin D₃. J Biol Chem 268,27371-80 (1993)

25. C. Zierold, H.M. Darwish & H.F. DeLuca: Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D₃) 24-hydroxylase gene. Proc Natl Acad Sci USA 91,900-2 (1994)

26. C. Carlberg, I. Bendik, A. Wyss, E. Meier, L. J. Sturzenbecker, J.F. Grippo & W. Hunziker: Two nuclear signalling pathways for vitamin D. Nature 361,657-60 (1993)

27. J. Liao, K.Ozono, T. Sone, D.P. McDonnell & J.W. Pike: Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D₃. Proc Natl Acad Sci USA 87,9751-5 (1990)

28. V.C. Yu, C. Delsert, B. Andersen, J.M. Holloway, O.V. Devary, A.M. Näär, S.Y. Kim, J.M. Boutin, C.K. Glass & M.G. Rosenfeld: RXRß: A coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 67,1251-66 (1991)

29. S.A. Kliewer, K. Umesono, D.J. Mangelsdorf & R.M. Evans: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D₃ signalling. Nature 355,446-9 (1992)

30. P.N. MacDonald, D.R. Dowd, S. Nakajima, M.A. Galligan, M.C. Reeder, C.A. Haussler, K. Ozato & M.R. Haussler: Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D₃-activated expression of the rat osteocalcin gene. Mol Cell Biol 13,5907-17 (1993)

31. R.A. Heyman, D.J. Mangelsdorf, J.A. Dyck, R.B. Stein, G. Eichele, R.M. Evans & C. Thaller: 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68,397-406 (1992)

32. A.A. Levin, L.J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, Cl. Kratzeisen, M. Rosenberger, A. Lovey & J.F. Grippo: 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRalpha. Nature 355,359-61 (1992)

33. D.J. Mangelsdorf, U. Borgmeyer, R.A. Heyman, J. Yang Zhou, E.S. Ong, A.E. Oro, A. Kakizuka & R.M. Evans: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6,329-44 (1992)

34. M. Schräder, I. Bendik, M. Becker-André & C. Carlberg: Interaction between retinoic acid and vitamin D signaling pathways. J Biol Chem 268,17830-6 (1993)

35. M. Schräder, K.M. Müller & C. Carlberg: Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269,5501-4 (1994)

36. M. Schräder, K.M. Müller, S. Nayeri, J.-P. Kahlen & C. Carlberg: Vitamin D₃-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 370,382-6 (1994)

37. S.J. Rhodes, R. Chen, G.E. DiMattia, K.M. Scully, K.A. Kalla, S.-C Lin, V.C. Yu & M.G. Rosenfeld: A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev 7,913-32 (1993)

38. R.K. Gill & S. Christakos: Identification of sequence elements in mouse calbindin-D_28k gene that confer 1,25-dihydroxyvitamin D₃- and butyrate-inducible responses. Proc Natl Acad Sci USA 90,2984-8 (1993)

39. S.A. Kerner, R.A. Scott & J.W. Pike: Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D₃. Proc Natl Acad Sci USA 86,4455-9 (1989)

40. N.A. Morrison, J. Shine, J.-C. Fragonas, V. Verkest, M.L. McMenemy & J.A. Eisman: 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246,1158-61 (1989)

41. M. Schräder, K.M. Müller, M. Becker-André & C. Carlberg: Response element specificity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors. J Mol Endocrinol 12, 327-9 (1994)

42. M. Schräder, S. Nayeri, J.-P. Kahlen, K.M. Müller & C. Carlberg: Natural vitamin D₃ response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D₃ receptor-retinoid X receptor heterodimer-mediated transactivation. Mol Cell Biol 15,1154-61 (1995)

43. B.Cheskis & L.P. Freedman: Ligand modulates the conversion of DNA-bound vitamin D₃ receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell Biol 14, 3329-38 (1994)

44. R. Kurokawa, V.C. Yu, A. Näär, S. Kyakumoto, Z. Han, S. Silverman, M.G. Rosenfeld & C.K. Glass: Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev 7, 1423-35 (1993)

45. J.L. Ransone & I.M. Verma: Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 6, 539-57 (1990)

46. A.E. Grigoriadis, Z.-Q. Wang & E.F. Wagner: Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet 11, 436-41 (1995)

47. G.A. Candeliere, J. Prud'homme & R. St-Arnaud: Differential stimulation of Fos and Jun family members by calcitriol in osteoblastic cells. Mol Endocrinol 5, 1780-1788 (1991)

48. G.A. Candeliere, P.W. Jurutka, M.R. Haussler & R. St-Arnaud: A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol Cell Biol 16, 584-92 (1996)

49. L. Guarente: Transcriptional coactivators in yeast and beyond. Trends Biochem Sci 20,517-21 (1995)

50. S. Fields & O. Song: A novel genetic system to detect protein-protein interactions. Nature 340, 245-7 (1989)

51. P.N. MacDonald, D.R. Sherman, D.R. Dowd, S.C. Jefcoat, Jr. & R.K. DeLisle: The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 270, 4748-52 (1995)

52. J.C.G. Blanco, I.-M. Wang, S.Y. Tsai, M.-J. Tsai, B.W. O'Malley, P.W. Jurutka, M.R. Haussler & K. Ozato: Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 92, 1535-9 (1995)

53. J.A. Goodrich, G. Cutler & R. Tjian: Contacts in context: promoter specificity and macromolecular interactions in transcription. Cell 84, 825-830 (1996)

54. M. Gstaiger, L. Knoepfel, O. Georgiev, W. Schaffner & C.M. Hovens: A B-cell coactivator of octamer-binding transcription factors. Nature 373, 360-2 (1995)

55. M. Strubin, J.W. Newell & P. Matthias: OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80, 497-506 (1995)

56. D. Apt, T. Chong, Y. Liu & H.U. Bernard: Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol 67, 4455-63 (1993)

57. T. Inoue, T. Tamura, T. Furuichi & K. Mikoshiba: Isolation of complementary DNAs encoding a cerebellum-enriched nuclear factor I family that activates transcription from the mouse myelin basic protein promoter. J Biol Chem 265, 19065-70 (1990)

58. K.A. Jones, K.R. Yamamoto & R. Tjian: Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 42,559-72 (1985)

59. K.A. Jones, J.T. Kadonaga, P.J. Rosenfeld, T.J. Kelly & R. Tjian: A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48,79-89 (1987)

60. C. Santoro, N. Mermod, P.C. Andrews & R. Tjian: A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature 334,218-24 (1988)

61. R.AW. Rupp, U. Kruse, G. Multhaup, U. Göbel, K. Beyreuther & A.E. Sippel: Chicken NF1/TGGCA proteins are encoded by at least three independent genes: NF1-A, NF1-B and NF1-C with homologues in mammalian genomes. Nucl Acids Res 18, 2607-16 (1990)

62. M.G. Toohey, J.W. Lee, M. Huang & D.O. Peterson: Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus. J Virol 64,4477-88 (1990)

63. B. Corthesy, J.R. Cardinaux, F.X. Claret & W. Wahli: A nuclear factor 1-like activity and a liver-specific repressor govern estrogen-regulated in vitro transcription from the Xenopus laevis vitellogenin B1 promoter. Mol Cell Biol 9,5548-62 (1989)

64. M. Liu & L.P. Freedman: Transcriptional synergism between the vitamin D₃ receptor and other nonreceptor transcription factors. Mol Endocrinol 8,1593-604 (1994)

65. L. Runkel, P.E. Shaw, R.E. Herrera, R.A. Hipskind & A. Nordheim: Multiple basal promoter elements determine the level of human c-fos transcription. Mol Cell Biol 11,1270-80 (1991)

66. S. Vukicevic, F.P. Luyten, H.K. Kleinman & A.H. Reddi: Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell. 63,437-45 (1990)

67. K. Traianedes, K.W. Ng, T.J. Martin & D.M. Findlay: Cell substratum modulates responses of preosteoblasts to retinoic acid. J Cell Physiol 157,243-52 (1993)

68. C.Y. Leung-Hagesteijn, K. Milankov, M. Michalak, J. Wilkins & S. Dedhar: Cell attachment to extracellular matrix substrates is inhibited upon downregulation of expression of calreticulin, an intracellular integrin alpha-subunit-binding protein. J Cell Sci 107,589-600 (1994)

69. M. Coppolino, Leung-Hagesteijn, C.Y., S. Dedhar & J. Wilkins: Inducible interaction of integrin alpha 2 beta 1 with calreticulin. Dependence on the activation state of the integrin. J Biol Chem 270,23132-8 (1995)

70. S. Dedhar, P.S. Rennie, M. Shago, C. Leung-Hagesteijn, H. Yang, J. Filmus, R.G. Hawley, N. Bruchovsky, H. Cheng, R.J. Matusik & V. Giguère: Inhibition of nuclear hormone receptor activity by calreticulin. Nature (Lond.) 367,480-3 (1994)

71. R. St-Arnaud, J. Prud'homme, C. Leung-Hagesteijn & S. Dedhar: Constitutive expression of calreticulin in osteoblasts inhibits mineralization. J Cell Biol 131, 1351-9 (1995)

72. L. Fliegel, K. Burns, M. Opas & M. Michalak: The high-affinity calcium binding protein of sarcoplasmic reticulum. Tissue distribution, and homology with calregulin. Biochem Biophys Acta 982,1-8 (1989)

73. R.E. Milner, S. Baksh, C. Shemanko, M.R. Carpenter, L. Smillie, J.E. Vance, M. Opas, and M. Michalak: Calreticulin & not calsequestrin, is the major calcium binding protein of smooth muscle sarcoplasmic reticulum and liver endoplasmic reticulum. J Biol Chem 266, 7155-65 (1991)

74. M. Michalak, R.E. Milner, K. Burns & M. Opas: Calreticulin. Biochem J 285,681-92 (1992)

75. N.K. Singh, C.D. Atreya & H.L. Nakhasi: Identification of calreticulin as a rubella virus RNA binding protein. Proc Natl Acad Sci USA 91, 12770-4 (1994)

76. M. Opas, E. Dziak, L. Fliegel & M. Michalak: Regulation of expression and intracellular distribution of calreticulin, a major calcium binding protein of nonmuscle cells. J Cell Physiol 149,160-71(1991)

77. M.V. Rojiani, B.B. Finlay, V. Gray & S. Dedhar: In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin a subunits. Biochemistry 30,9859-66 (1991)

78. M.A. Carson-Jurica, W.T. Schrader & B.W. O'Malley: Steroid receptor family: structures and functions. Endocrine Rev 11, 201-20 (1990)

79. Y. Severne, S. Wieland, W. Shaffner & S. Rusconi: Metal binding 'finger' structure in the glucocorticoid receptor defined by site-directed mutagenesis. EMBO J 7, 2503-8 (1988)

80. S. Dedhar : Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem Sciences 19,269-71 (1994)

81. K. Burns, B. Duggan, E.A. Atkinson, K.S. Famulski, M. Nemer, R.C. Bleackley & M. Michalak: Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature (Lond.) 367,476-80 (1994)

82. D.G. Wheeler, J. Horsford, M. Michalak, J.H. White & G.N. Hendy: Calreticulin inhibits vitamin D₃ signal transduction. Nucl Acids Res 23, 3268-74 (1995)

83. C.J. Winrow, K.S. Miyata, S.L. Marcus, K. Burns, M. Michalak, P.P. Capone & R.A. Rachubinski: Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor / retinoid X receptor heterodimers. Mol Cell Endocrinol 111, 175-9 (1995)

84. S. Rahman, A. Oberdorf, M. Montecino, S.M. Tanhauser, J.B. Lian, G.S. Stein, P.J. Laipis & J.L. Stein: Multiple copies of the bone-specific osteocalcin gene in mouse and rat. Endocrinology 133,3050-3 (1993)

85. E.C. Breen, A.J. vanWijnen, J.B. Lian, G.S. Stein & J.L. Stein: In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells. Proc Natl Acad Sci USA 91,12902-6 (1994)

86. R.S. Khoury, J. Weber & M.C. Farach-Carson: Vitamin D metabolites modulate osteoblast activity by Ca²⁺ influx-independent genomic and Ca²⁺ influx-dependent nongenomic pathways. J Nutr 125, 1699S-703S (1995)

87. R. St-Arnaud, A. Arabian & F.H. Glorieux: Perinatal lethality in mice homozygous for the targeted inactivation of vitamin D 24-hydroxylase. Bone 17, 573 (1995)